---
schema_version: "secwatch.filing_event.v1"
accession: "0001651944-24-000028"
form_type: "8-K"
ticker: null
cik: "0001651944"
company_name: "DermTech, Inc."
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:17:12.996185+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DermTech receives Nasdaq bid-price deficiency notice; has until Oct 14, 2024 to regain compliance

## Summary
- Received Nasdaq notice on April 15, 2024 for bid price below $1.00 for 30 consecutive business days.
- Must achieve closing bid price ≥$1.00 for at least 10 consecutive business days by October 14, 2024.
- If stock closes below $0.10 during compliance period, Nasdaq may issue a delisting determination.
- Company may qualify for a second 180-day compliance period if other listing standards are met.
- Notice does not immediately affect listing on Nasdaq Capital Market or business operations.

## SEC filing metadata
- accession: 0001651944-24-000028
- form_type: 8-K
- cik: 0001651944
- company_name: DermTech, Inc.
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000028/0001651944-24-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000028/dmtk-20240415.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651944-24-000028
- JSON: https://secwatch.observer/filing/0001651944-24-000028.json
- Plain text: https://secwatch.observer/filing/0001651944-24-000028.txt

## Key facts
- Listing & Compliance Notices
  DermTech, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)(iii)
  source text: April 15, 2024, DermTech, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), closed below the minimum $1.00 per share requirement for continued inclusion under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided a 180-calendar day compliance pe
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000028/0001651944-24-000028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.